OTCMREFG
Market cap0kUSD
Dec 19, Last price
0.00USD
1D
0.00%
Jan 2017
-100.00%
Name
Medical Cannabis Payment Solutions
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-34k
L-97.88%
CFO
-2k
L-99.42%
Profile
Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | 22 | 142 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (22) | (142) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | 3 | 2 | ||||||
Tax Rate | ||||||||
NOPAT | (22) | (142) | ||||||
Net income | (34) -97.88% | (1,608) 381.72% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 150 | |||||||
BB yield | -7.95% | |||||||
| Debt | ||||||||
Debt current | 858 | 858 | ||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | 833 | 831 | ||||||
| Cash flow | ||||||||
Cash from operating activities | (2) | (323) | ||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | 325 | |||||||
FCF | 12 | 1,241 | ||||||
| Balance | ||||||||
Cash | 2 | |||||||
Long term investments | 25 | 25 | ||||||
Excess cash | 25 | 27 | ||||||
Stockholders' equity | (2,267) | (2,233) | ||||||
Invested Capital | 797 | 797 | ||||||
ROIC | ||||||||
ROCE | 1.49% | 9.88% | ||||||
| EV | ||||||||
Common stock shares outstanding | 608,377 | 608,377 | ||||||
Price | 0.00 -51.61% | 0.00 -84.10% | ||||||
Market cap | 913 -51.61% | 1,886 -82.22% | ||||||
EV | 1,745 | 2,717 | ||||||
EBITDA | (120) | |||||||
EV/EBITDA | ||||||||
Interest | 420 | |||||||
Interest/NOPBT | ||||||||